Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system
Identifieur interne : 000072 ( PascalFrancis/Corpus ); précédent : 000071; suivant : 000073Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system
Auteurs : Marilyn L. Kwan ; LING SHEN ; Julie R. Munneke ; Emily K. Tam ; Paula N. Partee ; Mary Andre ; Susan E. Kutner ; Carol P. Somkin ; Lynn M. Ackerson ; Saskia R. J. ThiadensSource :
- Breast cancer research and treatment [ 0167-6806 ] ; 2012.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Breast cancer patients have voiced dissatisfaction regarding their education on breast cancer-related lymphedema risk and risk reduction strategies from their clinicians. Informing patients about lymphedema can contribute to decrease their risk of developing the condition, or among those already affected, prevent it from progressing further. In this cross-sectional study, a lymphedema awareness score was calculated based on responses to a brief telephone interview conducted among 389 women diagnosed with invasive breast cancer at Kaiser Permanente Northern California from 2000 to 2008 and had a previous record of a lymphedema-related diagnosis or procedure in their electronic medical record. During the telephone interview, women self-reported a lymphedema clinical diagnosis, lymphedema symptoms but no lymphedema diagnosis, or neither a diagnosis nor symptoms, and responded to questions on lymphedema education and support services as well as health knowledge. Multivariable logistic regression [odds ratio (OR) and 95 % confidence interval (CI)] was used to determine the associations of selected sociodemographic and clinical factors with the odds of having lymphedema awareness (adequate vs. inadequate). The median (range) of the lymphedema awareness score was 4 (0-7). Compared with patients <50 years of age, patients 70+ years of age at breast cancer diagnosis had lower odds of adequate lymphedema awareness (OR 0.25; 95 % CI 0.07, 0.89), while patients 50-59 and 60-69 years had greater odds of adequate awareness although not statistically significant (OR 2.05; 95 % CI 0.88, 4.78 and OR 1.55; 95 % CI 0.60, 4.02, respectively; p for trend = 0.09). Higher educational level and greater health literacy were suggestive of adequate awareness yet were not significant. These results can help inform educational interventions to strengthen patient knowledge of lymphedema risk and risk reduction practices, particularly in an integrated health care delivery setting. With the growing population of breast cancer survivors, increasing patient awareness and education about lymphedema risk reduction and care after cancer diagnosis is warranted.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 12-0362001 INIST |
---|---|
ET : | Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system |
AU : | KWAN (Marilyn L.); LING SHEN; MUNNEKE (Julie R.); TAM (Emily K.); PARTEE (Paula N.); ANDRE (Mary); KUTNER (Susan E.); SOMKIN (Carol P.); ACKERSON (Lynn M.); THIADENS (Saskia R. J.) |
AF : | Division of Research, Kaiser Permanente Northern California, 2000 Broadway/Oakland, CA 94612/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut., 5 aut., 8 aut., 9 aut.); Park Shadelands Medical Offices, Kaiser Permanente Northern California, 320 Lennon Lane/Walnut Creek, CA 94598/Etats-Unis (6 aut.); San Jose Medical Center. Kaiser Permanente Northern California, 280 Hospital Parkway/San Jose, CA 95119/Etats-Unis (7 aut.); National Lymphedema Network, 116 New Montgomery Street, Suite 235/San Francisco, CA 94105/Etats-Unis (10 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Breast cancer research and treatment; ISSN 0167-6806; Coden BCTRD6; Pays-Bas; Da. 2012; Vol. 135; No. 2; Pp. 591-602; Bibl. 32 ref. |
LA : | Anglais |
EA : | Breast cancer patients have voiced dissatisfaction regarding their education on breast cancer-related lymphedema risk and risk reduction strategies from their clinicians. Informing patients about lymphedema can contribute to decrease their risk of developing the condition, or among those already affected, prevent it from progressing further. In this cross-sectional study, a lymphedema awareness score was calculated based on responses to a brief telephone interview conducted among 389 women diagnosed with invasive breast cancer at Kaiser Permanente Northern California from 2000 to 2008 and had a previous record of a lymphedema-related diagnosis or procedure in their electronic medical record. During the telephone interview, women self-reported a lymphedema clinical diagnosis, lymphedema symptoms but no lymphedema diagnosis, or neither a diagnosis nor symptoms, and responded to questions on lymphedema education and support services as well as health knowledge. Multivariable logistic regression [odds ratio (OR) and 95 % confidence interval (CI)] was used to determine the associations of selected sociodemographic and clinical factors with the odds of having lymphedema awareness (adequate vs. inadequate). The median (range) of the lymphedema awareness score was 4 (0-7). Compared with patients <50 years of age, patients 70+ years of age at breast cancer diagnosis had lower odds of adequate lymphedema awareness (OR 0.25; 95 % CI 0.07, 0.89), while patients 50-59 and 60-69 years had greater odds of adequate awareness although not statistically significant (OR 2.05; 95 % CI 0.88, 4.78 and OR 1.55; 95 % CI 0.60, 4.02, respectively; p for trend = 0.09). Higher educational level and greater health literacy were suggestive of adequate awareness yet were not significant. These results can help inform educational interventions to strengthen patient knowledge of lymphedema risk and risk reduction practices, particularly in an integrated health care delivery setting. With the growing population of breast cancer survivors, increasing patient awareness and education about lymphedema risk reduction and care after cancer diagnosis is warranted. |
CC : | 002B20E02; 002B12B04 |
FD : | Homme; Malade; Connaissance; Cancer du sein; Lymphoedème; Système santé; Soin; Système administration; Education; Facteur risque |
FG : | Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein; Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques |
ED : | Human; Patient; Knowledge; Breast cancer; Lymphedema; Health system; Care; Delivery system; Education; Risk factor |
EG : | Malignant tumor; Cancer; Mammary gland diseases; Breast disease; Cardiovascular disease; Lymphatic vessel disease |
SD : | Hombre; Enfermo; Conocimiento; Cáncer del pecho; Linfedema; Sistema salud; Cuidado; Sistema administración; Educación; Factor riesgo |
LO : | INIST-20699.354000505101070240 |
ID : | 12-0362001 |
Links to Exploration step
Pascal:12-0362001Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system</title>
<author><name sortKey="Kwan, Marilyn L" sort="Kwan, Marilyn L" uniqKey="Kwan M" first="Marilyn L." last="Kwan">Marilyn L. Kwan</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ling Shen" sort="Ling Shen" uniqKey="Ling Shen" last="Ling Shen">LING SHEN</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Munneke, Julie R" sort="Munneke, Julie R" uniqKey="Munneke J" first="Julie R." last="Munneke">Julie R. Munneke</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Tam, Emily K" sort="Tam, Emily K" uniqKey="Tam E" first="Emily K." last="Tam">Emily K. Tam</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Partee, Paula N" sort="Partee, Paula N" uniqKey="Partee P" first="Paula N." last="Partee">Paula N. Partee</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Andre, Mary" sort="Andre, Mary" uniqKey="Andre M" first="Mary" last="Andre">Mary Andre</name>
<affiliation><inist:fA14 i1="02"><s1>Park Shadelands Medical Offices, Kaiser Permanente Northern California, 320 Lennon Lane</s1>
<s2>Walnut Creek, CA 94598</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kutner, Susan E" sort="Kutner, Susan E" uniqKey="Kutner S" first="Susan E." last="Kutner">Susan E. Kutner</name>
<affiliation><inist:fA14 i1="03"><s1>San Jose Medical Center. Kaiser Permanente Northern California, 280 Hospital Parkway</s1>
<s2>San Jose, CA 95119</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Somkin, Carol P" sort="Somkin, Carol P" uniqKey="Somkin C" first="Carol P." last="Somkin">Carol P. Somkin</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ackerson, Lynn M" sort="Ackerson, Lynn M" uniqKey="Ackerson L" first="Lynn M." last="Ackerson">Lynn M. Ackerson</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Thiadens, Saskia R J" sort="Thiadens, Saskia R J" uniqKey="Thiadens S" first="Saskia R. J." last="Thiadens">Saskia R. J. Thiadens</name>
<affiliation><inist:fA14 i1="04"><s1>National Lymphedema Network, 116 New Montgomery Street, Suite 235</s1>
<s2>San Francisco, CA 94105</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0362001</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0362001 INIST</idno>
<idno type="RBID">Pascal:12-0362001</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000072</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system</title>
<author><name sortKey="Kwan, Marilyn L" sort="Kwan, Marilyn L" uniqKey="Kwan M" first="Marilyn L." last="Kwan">Marilyn L. Kwan</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ling Shen" sort="Ling Shen" uniqKey="Ling Shen" last="Ling Shen">LING SHEN</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Munneke, Julie R" sort="Munneke, Julie R" uniqKey="Munneke J" first="Julie R." last="Munneke">Julie R. Munneke</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Tam, Emily K" sort="Tam, Emily K" uniqKey="Tam E" first="Emily K." last="Tam">Emily K. Tam</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Partee, Paula N" sort="Partee, Paula N" uniqKey="Partee P" first="Paula N." last="Partee">Paula N. Partee</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Andre, Mary" sort="Andre, Mary" uniqKey="Andre M" first="Mary" last="Andre">Mary Andre</name>
<affiliation><inist:fA14 i1="02"><s1>Park Shadelands Medical Offices, Kaiser Permanente Northern California, 320 Lennon Lane</s1>
<s2>Walnut Creek, CA 94598</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kutner, Susan E" sort="Kutner, Susan E" uniqKey="Kutner S" first="Susan E." last="Kutner">Susan E. Kutner</name>
<affiliation><inist:fA14 i1="03"><s1>San Jose Medical Center. Kaiser Permanente Northern California, 280 Hospital Parkway</s1>
<s2>San Jose, CA 95119</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Somkin, Carol P" sort="Somkin, Carol P" uniqKey="Somkin C" first="Carol P." last="Somkin">Carol P. Somkin</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ackerson, Lynn M" sort="Ackerson, Lynn M" uniqKey="Ackerson L" first="Lynn M." last="Ackerson">Lynn M. Ackerson</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Thiadens, Saskia R J" sort="Thiadens, Saskia R J" uniqKey="Thiadens S" first="Saskia R. J." last="Thiadens">Saskia R. J. Thiadens</name>
<affiliation><inist:fA14 i1="04"><s1>National Lymphedema Network, 116 New Montgomery Street, Suite 235</s1>
<s2>San Francisco, CA 94105</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast cancer</term>
<term>Care</term>
<term>Delivery system</term>
<term>Education</term>
<term>Health system</term>
<term>Human</term>
<term>Knowledge</term>
<term>Lymphedema</term>
<term>Patient</term>
<term>Risk factor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Homme</term>
<term>Malade</term>
<term>Connaissance</term>
<term>Cancer du sein</term>
<term>Lymphoedème</term>
<term>Système santé</term>
<term>Soin</term>
<term>Système administration</term>
<term>Education</term>
<term>Facteur risque</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Breast cancer patients have voiced dissatisfaction regarding their education on breast cancer-related lymphedema risk and risk reduction strategies from their clinicians. Informing patients about lymphedema can contribute to decrease their risk of developing the condition, or among those already affected, prevent it from progressing further. In this cross-sectional study, a lymphedema awareness score was calculated based on responses to a brief telephone interview conducted among 389 women diagnosed with invasive breast cancer at Kaiser Permanente Northern California from 2000 to 2008 and had a previous record of a lymphedema-related diagnosis or procedure in their electronic medical record. During the telephone interview, women self-reported a lymphedema clinical diagnosis, lymphedema symptoms but no lymphedema diagnosis, or neither a diagnosis nor symptoms, and responded to questions on lymphedema education and support services as well as health knowledge. Multivariable logistic regression [odds ratio (OR) and 95 % confidence interval (CI)] was used to determine the associations of selected sociodemographic and clinical factors with the odds of having lymphedema awareness (adequate vs. inadequate). The median (range) of the lymphedema awareness score was 4 (0-7). Compared with patients <50 years of age, patients 70+ years of age at breast cancer diagnosis had lower odds of adequate lymphedema awareness (OR 0.25; 95 % CI 0.07, 0.89), while patients 50-59 and 60-69 years had greater odds of adequate awareness although not statistically significant (OR 2.05; 95 % CI 0.88, 4.78 and OR 1.55; 95 % CI 0.60, 4.02, respectively; p for trend = 0.09). Higher educational level and greater health literacy were suggestive of adequate awareness yet were not significant. These results can help inform educational interventions to strengthen patient knowledge of lymphedema risk and risk reduction practices, particularly in an integrated health care delivery setting. With the growing population of breast cancer survivors, increasing patient awareness and education about lymphedema risk reduction and care after cancer diagnosis is warranted.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0167-6806</s0>
</fA01>
<fA02 i1="01"><s0>BCTRD6</s0>
</fA02>
<fA03 i2="1"><s0>Breast cancer res. treat.</s0>
</fA03>
<fA05><s2>135</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>KWAN (Marilyn L.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>LING SHEN</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>MUNNEKE (Julie R.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>TAM (Emily K.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>PARTEE (Paula N.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>ANDRE (Mary)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>KUTNER (Susan E.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>SOMKIN (Carol P.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>ACKERSON (Lynn M.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>THIADENS (Saskia R. J.)</s1>
</fA11>
<fA14 i1="01"><s1>Division of Research, Kaiser Permanente Northern California, 2000 Broadway</s1>
<s2>Oakland, CA 94612</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Park Shadelands Medical Offices, Kaiser Permanente Northern California, 320 Lennon Lane</s1>
<s2>Walnut Creek, CA 94598</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>San Jose Medical Center. Kaiser Permanente Northern California, 280 Hospital Parkway</s1>
<s2>San Jose, CA 95119</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>National Lymphedema Network, 116 New Montgomery Street, Suite 235</s1>
<s2>San Francisco, CA 94105</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA20><s1>591-602</s1>
</fA20>
<fA21><s1>2012</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20699</s2>
<s5>354000505101070240</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>32 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>12-0362001</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Breast cancer research and treatment</s0>
</fA64>
<fA66 i1="01"><s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Breast cancer patients have voiced dissatisfaction regarding their education on breast cancer-related lymphedema risk and risk reduction strategies from their clinicians. Informing patients about lymphedema can contribute to decrease their risk of developing the condition, or among those already affected, prevent it from progressing further. In this cross-sectional study, a lymphedema awareness score was calculated based on responses to a brief telephone interview conducted among 389 women diagnosed with invasive breast cancer at Kaiser Permanente Northern California from 2000 to 2008 and had a previous record of a lymphedema-related diagnosis or procedure in their electronic medical record. During the telephone interview, women self-reported a lymphedema clinical diagnosis, lymphedema symptoms but no lymphedema diagnosis, or neither a diagnosis nor symptoms, and responded to questions on lymphedema education and support services as well as health knowledge. Multivariable logistic regression [odds ratio (OR) and 95 % confidence interval (CI)] was used to determine the associations of selected sociodemographic and clinical factors with the odds of having lymphedema awareness (adequate vs. inadequate). The median (range) of the lymphedema awareness score was 4 (0-7). Compared with patients <50 years of age, patients 70+ years of age at breast cancer diagnosis had lower odds of adequate lymphedema awareness (OR 0.25; 95 % CI 0.07, 0.89), while patients 50-59 and 60-69 years had greater odds of adequate awareness although not statistically significant (OR 2.05; 95 % CI 0.88, 4.78 and OR 1.55; 95 % CI 0.60, 4.02, respectively; p for trend = 0.09). Higher educational level and greater health literacy were suggestive of adequate awareness yet were not significant. These results can help inform educational interventions to strengthen patient knowledge of lymphedema risk and risk reduction practices, particularly in an integrated health care delivery setting. With the growing population of breast cancer survivors, increasing patient awareness and education about lymphedema risk reduction and care after cancer diagnosis is warranted.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B20E02</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B12B04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Homme</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Human</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Malade</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Patient</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Enfermo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Connaissance</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Knowledge</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Conocimiento</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Cancer du sein</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Breast cancer</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Cáncer del pecho</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Système santé</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Health system</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Sistema salud</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Soin</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Care</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Cuidado</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Système administration</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Delivery system</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Sistema administración</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Education</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Education</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Educación</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Facteur risque</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Risk factor</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Factor riesgo</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Tumeur maligne</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Malignant tumor</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Tumor maligno</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Cáncer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie de la glande mammaire</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du sein</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Breast disease</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Seno patología</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie de l'appareil circulatoire</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie des vaisseaux lymphatiques</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>41</s5>
</fC07>
<fN21><s1>282</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 12-0362001 INIST</NO>
<ET>Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system</ET>
<AU>KWAN (Marilyn L.); LING SHEN; MUNNEKE (Julie R.); TAM (Emily K.); PARTEE (Paula N.); ANDRE (Mary); KUTNER (Susan E.); SOMKIN (Carol P.); ACKERSON (Lynn M.); THIADENS (Saskia R. J.)</AU>
<AF>Division of Research, Kaiser Permanente Northern California, 2000 Broadway/Oakland, CA 94612/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut., 5 aut., 8 aut., 9 aut.); Park Shadelands Medical Offices, Kaiser Permanente Northern California, 320 Lennon Lane/Walnut Creek, CA 94598/Etats-Unis (6 aut.); San Jose Medical Center. Kaiser Permanente Northern California, 280 Hospital Parkway/San Jose, CA 95119/Etats-Unis (7 aut.); National Lymphedema Network, 116 New Montgomery Street, Suite 235/San Francisco, CA 94105/Etats-Unis (10 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Breast cancer research and treatment; ISSN 0167-6806; Coden BCTRD6; Pays-Bas; Da. 2012; Vol. 135; No. 2; Pp. 591-602; Bibl. 32 ref.</SO>
<LA>Anglais</LA>
<EA>Breast cancer patients have voiced dissatisfaction regarding their education on breast cancer-related lymphedema risk and risk reduction strategies from their clinicians. Informing patients about lymphedema can contribute to decrease their risk of developing the condition, or among those already affected, prevent it from progressing further. In this cross-sectional study, a lymphedema awareness score was calculated based on responses to a brief telephone interview conducted among 389 women diagnosed with invasive breast cancer at Kaiser Permanente Northern California from 2000 to 2008 and had a previous record of a lymphedema-related diagnosis or procedure in their electronic medical record. During the telephone interview, women self-reported a lymphedema clinical diagnosis, lymphedema symptoms but no lymphedema diagnosis, or neither a diagnosis nor symptoms, and responded to questions on lymphedema education and support services as well as health knowledge. Multivariable logistic regression [odds ratio (OR) and 95 % confidence interval (CI)] was used to determine the associations of selected sociodemographic and clinical factors with the odds of having lymphedema awareness (adequate vs. inadequate). The median (range) of the lymphedema awareness score was 4 (0-7). Compared with patients <50 years of age, patients 70+ years of age at breast cancer diagnosis had lower odds of adequate lymphedema awareness (OR 0.25; 95 % CI 0.07, 0.89), while patients 50-59 and 60-69 years had greater odds of adequate awareness although not statistically significant (OR 2.05; 95 % CI 0.88, 4.78 and OR 1.55; 95 % CI 0.60, 4.02, respectively; p for trend = 0.09). Higher educational level and greater health literacy were suggestive of adequate awareness yet were not significant. These results can help inform educational interventions to strengthen patient knowledge of lymphedema risk and risk reduction practices, particularly in an integrated health care delivery setting. With the growing population of breast cancer survivors, increasing patient awareness and education about lymphedema risk reduction and care after cancer diagnosis is warranted.</EA>
<CC>002B20E02; 002B12B04</CC>
<FD>Homme; Malade; Connaissance; Cancer du sein; Lymphoedème; Système santé; Soin; Système administration; Education; Facteur risque</FD>
<FG>Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein; Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques</FG>
<ED>Human; Patient; Knowledge; Breast cancer; Lymphedema; Health system; Care; Delivery system; Education; Risk factor</ED>
<EG>Malignant tumor; Cancer; Mammary gland diseases; Breast disease; Cardiovascular disease; Lymphatic vessel disease</EG>
<SD>Hombre; Enfermo; Conocimiento; Cáncer del pecho; Linfedema; Sistema salud; Cuidado; Sistema administración; Educación; Factor riesgo</SD>
<LO>INIST-20699.354000505101070240</LO>
<ID>12-0362001</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000072 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000072 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:12-0362001 |texte= Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system }}
![]() | This area was generated with Dilib version V0.6.31. | ![]() |